{
    "Individual": {
        "Species": "Human",
        "Population": "European_ICRP_2002",
        "Gender": "MALE",
        "Age": 0,
         "Enzymes": [{
            "Name": "CYP3A4",
            "ReferenceConcentration": 3,
            "Expressions": {
                "Pericentral": 1,
                "Periportal": 1,
                "Duodenum": 0.5
            }
        }]
    },
    "Compounds": [{
        "Name": "drug",
        "Lipophilicity": 3,
        "FractionUnbound": 0.8,
        "MolWeight": 4E-7,
        "SolubilityAtRefpH": 1E-7,
        "RefpH": 9,
        "PkaTypes": [{
            "Type": "Acid",
            "Value": 8
        }],
        "CalculationMethods": ["Cellular partition coefficient method - Rodgers and Rowland"],
        "PartialProcesses": [
            {
                "MoleculeName": "CYP3A4",
                "InternalName": "MetabolizationSpecific_FirstOrder",
                "DataSource": "Lab",
                "ParameterValues": {"Specific clearance": 3}
            },
        ]
    }],
     "ApplicationProtocols": [{
        "DosingInterval": "Single",
        "ApplicationType": "Oral",
        "Dose": 10,
        "DoseUnit": "mg",
        "EndTime": 1440
     }],
    "Formulation":{
        "Name": "F",
        "FormulationType": "Formulation_Dissolved"
    },
    "Configuration": {
        "Model": "4Comp",
        "EndTime": 525600,
        "AllowAging":  true,
        "RelTol": 1e-8,
        "AbsTol": 1e-13,
        "CheckForNegativeValues": true
    }
}